866-997-4948(US-Canada Toll Free)

EMEA (Europe,Middle East and Africa) Generic Drugs Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 117 Pages

In this report, the EMEA Generic Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Generic Drugs for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Generic Drugs market competition by top manufacturers/players, with Generic Drugs sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Simple Generic Drugs
Super Generic Drugs
Biosimilars

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Table of Contents

EMEA (Europe, Middle East and Africa) Generic Drugs Market Report 2018
1 Generic Drugs Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Classification of Generic Drugs
1.2.1 EMEA Generic Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Generic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Simple Generic Drugs
1.2.4 Super Generic Drugs
1.2.5 Biosimilars
1.3 EMEA Generic Drugs Market by Application/End Users
1.3.1 EMEA Generic Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 EMEA Generic Drugs Market by Region
1.4.1 EMEA Generic Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Generic Drugs (2013-2025)
1.5.1 EMEA Generic Drugs Sales and Growth Rate (2013-2025)
1.5.2 EMEA Generic Drugs Revenue and Growth Rate (2013-2025)

2 EMEA Generic Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Generic Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Generic Drugs Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Generic Drugs Revenue and Share by Players (2013-2018)
2.1.3 EMEA Generic Drugs Sale Price by Players (2013-2018)
2.2 EMEA Generic Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Generic Drugs Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Generic Drugs Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Generic Drugs Sale Price by Type (2013-2018)
2.3 EMEA Generic Drugs (Volume) by Application
2.4 EMEA Generic Drugs (Volume and Value) by Region
2.4.1 EMEA Generic Drugs Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Generic Drugs Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Generic Drugs Sales Price by Region (2013-2018)

3 Europe Generic Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Generic Drugs Sales and Value (2013-2018)
3.1.1 Europe Generic Drugs Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Generic Drugs Revenue and Growth Rate (2013-2018)
3.2 Europe Generic Drugs Sales and Market Share by Type
3.3 Europe Generic Drugs Sales and Market Share by Application
3.4 Europe Generic Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Generic Drugs Sales Volume by Countries (2013-2018)
3.4.2 Europe Generic Drugs Revenue by Countries (2013-2018)
3.4.3 Germany Generic Drugs Sales and Growth Rate (2013-2018)
3.4.4 France Generic Drugs Sales and Growth Rate (2013-2018)
3.4.5 UK Generic Drugs Sales and Growth Rate (2013-2018)
3.4.6 Russia Generic Drugs Sales and Growth Rate (2013-2018)
3.4.7 Italy Generic Drugs Sales and Growth Rate (2013-2018)
3.4.8 Benelux Generic Drugs Sales and Growth Rate (2013-2018)

4 Middle East Generic Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Generic Drugs Sales and Value (2013-2018)
4.1.1 Middle East Generic Drugs Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Generic Drugs Revenue and Growth Rate (2013-2018)
4.2 Middle East Generic Drugs Sales and Market Share by Type
4.3 Middle East Generic Drugs Sales and Market Share by Application
4.4 Middle East Generic Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Generic Drugs Sales Volume by Countries (2013-2018)
4.4.2 Middle East Generic Drugs Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Generic Drugs Sales and Growth Rate (2013-2018)
4.4.4 Israel Generic Drugs Sales and Growth Rate (2013-2018)
4.4.5 UAE Generic Drugs Sales and Growth Rate (2013-2018)
4.4.6 Iran Generic Drugs Sales and Growth Rate (2013-2018)

5 Africa Generic Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Generic Drugs Sales and Value (2013-2018)
5.1.1 Africa Generic Drugs Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Generic Drugs Revenue and Growth Rate (2013-2018)
5.2 Africa Generic Drugs Sales and Market Share by Type
5.3 Africa Generic Drugs Sales and Market Share by Application
5.4 Africa Generic Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Generic Drugs Sales Volume by Countries (2013-2018)
5.4.2 Africa Generic Drugs Revenue by Countries (2013-2018)
5.4.3 South Africa Generic Drugs Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Generic Drugs Sales and Growth Rate (2013-2018)
5.4.5 Egypt Generic Drugs Sales and Growth Rate (2013-2018)
5.4.6 Algeria Generic Drugs Sales and Growth Rate (2013-2018)

6 EMEA Generic Drugs Manufacturers/Players Profiles and Sales Data
6.1 Teva
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Generic Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Novartis - Sandoz
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Generic Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Mylan
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Generic Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Generic Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Aspen
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Generic Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Fresenius Kabi
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Generic Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Pfizer (Hospira)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Generic Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Generic Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Aurobindo
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Generic Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Lupin
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Generic Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Dr. Reddy's
6.12 Apotex
6.13 Cipla
6.14 ENDO (Par Pharmaceutical)
6.15 Stada Arzneimittel
6.16 Krka Group
6.17 Nichi-Iko Pharmaceutical
6.18 Valeant
6.19 Zydus Cadila
6.20 Hikma

7 Generic Drugs Manufacturing Cost Analysis
7.1 Generic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Generic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Generic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Generic Drugs Market Forecast (2018-2025)
11.1 EMEA Generic Drugs Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Generic Drugs Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Generic Drugs Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Generic Drugs Price and Trend Forecast (2018-2025)
11.2 EMEA Generic Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Generic Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Generic Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Generic Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Generic Drugs Sales Forecast by Type (2018-2025)
11.7 EMEA Generic Drugs Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Generic Drugs
Figure EMEA Generic Drugs Sales Volume (K MT) by Type (2013-2025)
Figure EMEA Generic Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Simple Generic Drugs Product Picture
Figure Super Generic Drugs Product Picture
Figure Biosimilars Product Picture
Figure EMEA Generic Drugs Sales Volume (K MT) by Application (2013-2025)
Figure EMEA Sales Market Share of Generic Drugs by Application in 2017
Figure CNS Examples
Table Key Downstream Customer in CNS
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Genitourinary/Hormonal Drugs Examples
Table Key Downstream Customer in Genitourinary/Hormonal Drugs
Figure Respiratory Examples
Table Key Downstream Customer in Respiratory
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Generic Drugs Market Size (Million USD) by Region (2013-2025)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Generic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Generic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Generic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Generic Drugs Sales Volume and Growth Rate (2013-2025)
Figure EMEA Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Generic Drugs Market Major Players Product Sales Volume (K MT) (2013-2018)
Table EMEA Generic Drugs Sales Volume (K MT) of Major Players (2013-2018)
Table EMEA Generic Drugs Sales Share by Players (2013-2018)
Figure 2017 Generic Drugs Sales Share by Players
Figure 2017 Generic Drugs Sales Share by Players
Figure EMEA Generic Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Generic Drugs Revenue (Million USD) by Players (2013-2018)
Table EMEA Generic Drugs Revenue Share by Players (2013-2018)
Table 2017 EMEA Generic Drugs Revenue Share by Players
Table 2017 EMEA Generic Drugs Revenue Share by Players
Table EMEA Generic Drugs Sale Price (USD/MT) by Players (2013-2018)
Table EMEA Generic Drugs Sales (K MT) and Market Share by Type (2013-2018)
Table EMEA Generic Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Generic Drugs by Type (2013-2018)
Figure EMEA Generic Drugs Sales Market Share by Type (2013-2018)
Table EMEA Generic Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Generic Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Generic Drugs by Type in 2017
Table EMEA Generic Drugs Sale Price (USD/MT) by Type (2013-2018)
Table EMEA Generic Drugs Sales (K MT) and Market Share by Application (2013-2018)
Table EMEA Generic Drugs Sales Share by Application (2013-2018)
Figure Sales Market Share of Generic Drugs by Application (2013-2018)
Figure EMEA Generic Drugs Sales Market Share by Application in 2017
Table EMEA Generic Drugs Sales (K MT) and Market Share by Region (2013-2018)
Table EMEA Generic Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Generic Drugs by Region (2013-2018)
Figure EMEA Generic Drugs Sales Market Share in 2017
Table EMEA Generic Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Generic Drugs Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Generic Drugs by Region (2013-2018)
Figure EMEA Generic Drugs Revenue Market Share Regions in 2017
Table EMEA Generic Drugs Sales Price (USD/MT) by Region (2013-2018)
Figure Europe Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Europe Generic Drugs Revenue and Growth Rate (2013-2018)
Table Europe Generic Drugs Sales (K MT) by Type (2013-2018)
Table Europe Generic Drugs Market Share by Type (2013-2018)
Figure Europe Generic Drugs Market Share by Type in 2017
Table Europe Generic Drugs Sales (K MT) by Application (2013-2018)
Table Europe Generic Drugs Market Share by Application (2013-2018)
Figure Europe Generic Drugs Market Share by Application in 2017
Table Europe Generic Drugs Sales (K MT) by Countries (2013-2018)
Table Europe Generic Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Generic Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Generic Drugs Sales Market Share by Countries in 2017
Table Europe Generic Drugs Revenue (Million USD) by Countries (2013-2018)
Table Europe Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Generic Drugs Revenue Market Share by Countries in 2017
Figure Germany Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure France Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure UK Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Russia Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Italy Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Benelux Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Middle East Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Middle East Generic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Generic Drugs Sales (K MT) by Type (2013-2018)
Table Middle East Generic Drugs Market Share by Type (2013-2018)
Figure Middle East Generic Drugs Market Share by Type (2013-2018)
Table Middle East Generic Drugs Sales (K MT) by Applications (2013-2018)
Table Middle East Generic Drugs Market Share by Applications (2013-2018)
Figure Middle East Generic Drugs Sales Market Share by Application in 2017
Table Middle East Generic Drugs Sales Volume (K MT) by Countries (2013-2018)
Table Middle East Generic Drugs Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Generic Drugs Sales Volume Market Share by Countries in 2017
Table Middle East Generic Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Generic Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Israel Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure UAE Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Iran Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Africa Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Africa Generic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Generic Drugs Sales (K MT) by Type (2013-2018)
Table Africa Generic Drugs Sales Market Share by Type (2013-2018)
Figure Africa Generic Drugs Sales Market Share by Type (2013-2018)
Figure Africa Generic Drugs Sales Market Share by Type in 2017
Table Africa Generic Drugs Sales (K MT) by Application (2013-2018)
Table Africa Generic Drugs Sales Market Share by Application (2013-2018)
Figure Africa Generic Drugs Sales Market Share by Application (2013-2018)
Table Africa Generic Drugs Sales Volume (K MT) by Countries (2013-2018)
Table Africa Generic Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Generic Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Generic Drugs Sales Market Share by Countries in 2017
Table Africa Generic Drugs Revenue (Million USD) by Countries (2013-2018)
Table Africa Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Generic Drugs Revenue Market Share by Countries in 2017
Figure South Africa Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Nigeria Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Egypt Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Algeria Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Table Teva Generic Drugs Basic Information List
Table Teva Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Teva Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Teva Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Teva Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Novartis - Sandoz Generic Drugs Basic Information List
Table Novartis - Sandoz Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis - Sandoz Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Novartis - Sandoz Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Novartis - Sandoz Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Mylan Generic Drugs Basic Information List
Table Mylan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Mylan Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Mylan Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Mylan Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Sun Pharmaceutical Generic Drugs Basic Information List
Table Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Aspen Generic Drugs Basic Information List
Table Aspen Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Aspen Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Aspen Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Aspen Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Fresenius Kabi Generic Drugs Basic Information List
Table Fresenius Kabi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Fresenius Kabi Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Fresenius Kabi Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Fresenius Kabi Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Pfizer (Hospira) Generic Drugs Basic Information List
Table Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Sanofi Generic Drugs Basic Information List
Table Sanofi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Sanofi Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Sanofi Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Aurobindo Generic Drugs Basic Information List
Table Aurobindo Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Aurobindo Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Aurobindo Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Aurobindo Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Lupin Generic Drugs Basic Information List
Table Lupin Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Lupin Generic Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Lupin Generic Drugs Sales Market Share in EMEA (2013-2018)
Figure Lupin Generic Drugs Revenue Market Share in EMEA (2013-2018)
Table Dr. Reddy's Generic Drugs Basic Information List
Table Apotex Generic Drugs Basic Information List
Table Cipla Generic Drugs Basic Information List
Table ENDO (Par Pharmaceutical) Generic Drugs Basic Information List
Table Stada Arzneimittel Generic Drugs Basic Information List
Table Krka Group Generic Drugs Basic Information List
Table Nichi-Iko Pharmaceutical Generic Drugs Basic Information List
Table Valeant Generic Drugs Basic Information List
Table Zydus Cadila Generic Drugs Basic Information List
Table Hikma Generic Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Generic Drugs
Figure Manufacturing Process Analysis of Generic Drugs
Figure Generic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Generic Drugs Major Manufacturers in 2017
Table Major Buyers of Generic Drugs
Table Distributors/Traders List
Figure EMEA Generic Drugs Sales (K MT) and Growth Rate Forecast (2018-2025)
Figure EMEA Generic Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Generic Drugs Price (USD/MT) and Trend Forecast (2018-2025)
Table EMEA Generic Drugs Sales (K MT) Forecast by Region (2018-2025)
Figure EMEA Generic Drugs Sales Market Share Forecast by Region (2018-2025)
Table EMEA Generic Drugs Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Generic Drugs Revenue Market Share Forecast by Region (2018-2025)
Table Europe Generic Drugs Sales (K MT) Forecast by Countries (2018-2025)
Figure Europe Generic Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Europe Generic Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Generic Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Generic Drugs Sales (K MT) Forecast by Countries (2018-2025)
Figure Middle East Generic Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Generic Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Generic Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Generic Drugs Sales (K MT) Forecast by Countries (2018-2025)
Figure Africa Generic Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Africa Generic Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Generic Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Generic Drugs Sales (K MT) Forecast by Type (2018-2025)
Figure EMEA Generic Drugs Sales Market Share Forecast by Type (2018-2025)
Table EMEA Generic Drugs Sales (K MT) Forecast by Application (2018-2025)
Figure EMEA Generic Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *